NCT05874674View on ClinicalTrials.gov

The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Dialysis; ComplicationsBleeding
Interventions
DRUG

Nafamostat Mesylate

Comparison effect of nafamostat and cnoxan

Trial Locations (1)

26426

RECRUITING

Yonsei Unviersity Wonju College of Medicin, Wŏnju

All Listed Sponsors
lead

Wonju Severance Christian Hospital

OTHER